As 2026 approaches, the healthcare M&A landscape is predicted to accelerate, driven by stabilizing interest rates, a backlog of private equity (PE) dry powder, and sustained demographic demand. For owners considering selling a healthcare business to capture peak valuation, understanding where institutional capital is flowing is essential.
As we look toward the new year, M&A trends in the Intellectual and Developmental Disabilities (IDD) and treatment center sectors, as well as the resilient Home Health market, are the focus. Private Equity is not simply acquiring assets; they are building sophisticated, technology-enabled platforms designed for the future of value-based care.
Here is a targeted forecast for where major PE investment will land in the upcoming year, along with clear steps you can take now to position your agency as a high-value platform.
1. Home Health & Post-Acute Care: Why Demographics Drive Deal Flow
Home health continues to be the bedrock of healthcare M&A, simply because the math works: the population is aging, and care is shifting away from the hospital. Despite recent noise about Medicare rate adjustments, smart capital is still chasing high-quality assets here. Regulatory risks, such as Medicare rate adjustments, are always concerning, but issues like this only sharpened the focus on high-quality assets.
The PE Target Profile: Integration and Efficiency
Private Equity firms are specifically targeting agencies that demonstrate:
- Controlling Payer Mix: Agencies successfully navigating the Medicare Advantage (MA) landscape and showing profitability via a selective payer mix are preferred.
- Operational Cleanliness: Buyers are highly selective, scrutinizing compliance and billing. Diligence is the most critical phase of the post-LOI process – clean clinical and Quality of Earnings (QOE) reports are key to arriving at a successful close.
- Technology Enablement: Companies utilizing new and effective technology in their operations are seeing strong interest from buyers. Tech integration signals efficiency and scalability.
2. Behavioral Health: Consolidation in a Fragmented Market
The market for behavioral health businesses is currently defined by intense demand and fragmentation, making it a prime target for PE consolidation (“roll-up” strategy). Both IDD businesses and Substance Use Disorder (SUD) treatment centers are seeing strong deal flow.
The PE Target Profile: Specialization and Scale
The market is favoring providers that offer specialized, high-demand services that can be scaled nationally:
- IDD & Autism (ABA Therapy): We are seeing aggressive Private Equity interest in the IDD space for 2025. Why? Because it’s recession-proof. Investors love the predictable, Medicaid-funded revenue streams and the ‘sticky’ nature of the patient base. PE is looking for regional platform assets with established clinical protocols and strong outcomes.
- Outpatient & Telehealth: Outpatient centers and telehealth platforms are attractive due to lower capital intensity compared to acute-care facilities. Buyers are seeking providers that offer a blended, “hybrid care” model to maximize reach and efficiency.
3. The Blueprint for a Successful 2026 Exit
For owners planning an early 2026 exit, the time to build momentum is now. Make no mistake: diligence is getting tougher. Buyers today aren’t just looking for growth; they are digging deep to verify that your growth is sustainable and your operations are clean.
Seller Action Plan:
| Priority Area | Strategic Action |
| Financial Preparation | Get your financials in order and model out your trailing-twelve-month (TTM) AEBITDA. |
| Growth Proof | Work on and document referral sources and payer metrics that demonstrate a mix and concentration consistent with a strong bottom line and minimal post-close risk to buyers. |
| Regulatory Foresight | Ensure all licensing, certifications, and state and federal compliance documents are in order. Non-compliance can be a deal-breaker. (See: Key Strategies for Successful M&A in the Health Sector) |
| M&A Expertise | Going to market and maximizing valuation and deal terms takes preparation. The more time you have to prepare and organize your information to present to buyers, the better. These transactions are sophisticated and lengthy – preparation is key. |
Capitalizing on Momentum: The Time to Act is Now
The window for selling a healthcare business is dictated by the confluence of market demand, credit availability, and regulatory stability. Current forecasts suggest a measured but strong home health mergers and acquisitions environment heading into Q1 2026, creating optimal conditions for motivated sellers.
If your business has strong EBITDA, clean compliance, and operates in a high-demand vertical like home health or behavioral health, you are uniquely positioned to benefit from the current wave of PE investment.
It’s impossible to time the peak of any market; it’s a moving target. Instead, focus on preparation. Whether you are in Home Health or the behavioral health sector, the difference between an average exit and a premium valuation usually comes down to who you have in your corner before the sale process begins.
(For an expert perspective on engaging the right buyers, read: How Selling a Home Health or Hospice Agency is Like a Fine Art Auction.)
Stoneridge Partners specializes in home health, home care, hospice, and behavioral health M&A, helping owners position their agencies to capture the highest possible valuation from strategic and private equity buyers.
Contact us for a confidential discussion to determine your Q1 2026 exit strategy.
Ben Bogan, J.D., Partner and Managing Director at Stoneridge Partners, has been a leading figure in healthcare M&A since 2014, specializing in home health, home care, and hospice transactions. With over 70 successful closed deals, Ben’s experience and expertise have set him apart as a skilled and invaluable intermediary in the industry.
With a law degree from Albany Law School, a BSBA in Economics from the University of Florida, and his background as a former Assistant District Attorney and Assistant District Counsel for the U.S. Army Corps of Engineers, Ben combines his legal background and M&A expertise to deliver exceptional results in every transaction. Available to his clients 24/7, Ben builds strong relationships with his clients and has garnered rave reviews.
For more information, please contact Ben directly at 520-991-4653 or [email protected]. All communications are confidential.
